Dr. Dominic, the board certified Tampa facial plastic surgeon at Elite Facial Plastic surgery will be among the first to gain exclusive access to XEOMIN® in the Tampa Bay area. Merz Aesthetics on July 21, 2011 announced that the United States (U.S.) Food and Drug Administration (FDA) has approved XEOMIN® (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
Tampa, FL (December 2011) – At this Tampa, FL plastic surgery practice, Elite Facial Plastic surgery is announcing the addition of a new facial rejuvenation procedure known as XEOMIN. We are very excited to be able to offer our patients this procedure following the success of the FDA approval process. Dennis Condon, President and Chief Business Officer of Merz Aesthetics, Inc., had this to say about the approval: “The FDA approval of XEOMIN is a significant milestone for Merz Aesthetics and a promising addition to our entire aesthetics franchise. We are confident that XEOMIN will provide patients and physicians with a new option for improving the appearance of glabellar lines.”
“XEOMIN is a promising new option for both patients and physicians and we are encouraged by the response rates seen in the Phase III clinical trials,” said Derek H. Jones, M.D., an investigator for the XEOMIN U.S. study, Clinical Associate Professor of Medicine at the University of California in Los Angeles, Calif., and Director of Skin Care and Laser Physicians in Beverly Hills, Calif.
The approval of XEOMIN is based on the results of two pivotal U.S. clinical trials involving 16 investigational sites and included 547 healthy adult patients. In both studies, XEOMIN significantly improved the appearance of glabellar lines 30 days following the first injection, when compared to placebo. XEOMIN is the only botulinum toxin currently approved in the U.S. that does not require refrigeration prior to reconstitution.
XEOMIN is approved for the temporary improvement in the appearance of glabellar lines in 14 countries in the European Union (EU), including Germany, the United Kingdom, France, Italy and Spain, under the brand name BOCOUTURE®.
XEOMIN will be available nationwide to physicians in the spring of 2012, but is available now at The Elite Facial Plastic Surgery. In addition, Elite Facial Plastic Surgery has been chosen to be a part of the XEOMIN Medical Advisory Board. XEOMIN differs from BOTOX® Cosmetic because it lacks proteins that may induce antibodies that can lessen its effectiveness. “XEOMIN represents an FDA approved alternative to BOTOX® which is less expensive yet equally effective for reduction of facial lines and wrinkles and control of excessive sweating.”
Elite Facial Plastic Surgery is located at 13801 Bruce B. Downs Blvd. Suite 305, Tampa, FL 33606, and can be reached at 813-975-3223 or (888) 975-3223.